IS PLASMINOGEN ACTIVATOR INHIBITOR-1 ASSOCIATED WITH DIABETIC RETINOPATHY AND ITS SEVERITY IN TYPE 2 DIABETIC PATIENTS?

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

BONAKDARAN SHOKOUFEH; SHOEIBI NASER

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Medical Journal of Mashhad University of Medical Sciences Year:2016 | Volume:58 | Issue:10 Page(s): 603-610

Download Full-Text

Persian Verion

View:

576

Download:

Cites:

Information Journal Paper

Title

IS PLASMINOGEN ACTIVATOR INHIBITOR-1 ASSOCIATED WITH DIABETIC RETINOPATHY AND ITS SEVERITY IN TYPE 2 DIABETIC PATIENTS?

Author(s)

BONAKDARAN SHOKOUFEH | SHOEIBI NASER | Issue Writer Certificate

Keywords

DIABETESQ2

RETINOPATHYQ2

PLASMINOGEN ACTIVATOR INHIBITOR 1Q2

HEMOSTASIS"TQ3

Abstract

Introduction: PLASMINOGEN ACTIVATOR INHIBITOR 1 (PAI-1) is a known cardiovascular risk marker in DIABETES but its role in microvascular disease is not clear. The aim of this study was to evaluate relationship between serum PAI-1 level and presence and severity of RETINOPATHY in type 2 diabetic patients.Methods: 175 type 2 diabetic patients were selected. Fasting vein samples were taken for assessment of fasting blood sugar, HbA1C, lipid profiles, creatinin and PAI-1. Urine was taken for assessment of microalbumin to creatinine ratio. All these patients then referred to the ophthalmologist for the evaluation of probable RETINOPATHY. The correlation between serum indices like PAI-1 and RETINOPATHY was assessed.Results: 59 patients (33.9%) had RETINOPATHY. There was significant relation between albuminuria, systolic blood pressure and HbA1c with diabetic RETINOPATHY. There was not significant relationship between RETINOPATHY and serum PAI-1 level. PAI-1 was not different between non proliferative RETINOPATHY compared with proliferative RETINOPATHY.Conclusion: No significant statistical association was found between serum PAI-1 level and occurrence of RETINOPATHY and its severity in diabetic patients but this observation remains to be determined by large clinical studies.

Cites

No record.

References

No record.

Cite

APA: Copy

BONAKDARAN, SHOKOUFEH, & SHOEIBI, NASER. (2016). IS PLASMINOGEN ACTIVATOR INHIBITOR-1 ASSOCIATED WITH DIABETIC RETINOPATHY AND ITS SEVERITY IN TYPE 2 DIABETIC PATIENTS?. MEDICAL JOURNAL OF MASHHAD UNIVERSITY OF MEDICAL SCIENCES, 58(10), 603-610. SID. https://sid.ir/paper/52192/en

Vancouver: Copy

BONAKDARAN SHOKOUFEH, SHOEIBI NASER. IS PLASMINOGEN ACTIVATOR INHIBITOR-1 ASSOCIATED WITH DIABETIC RETINOPATHY AND ITS SEVERITY IN TYPE 2 DIABETIC PATIENTS?. MEDICAL JOURNAL OF MASHHAD UNIVERSITY OF MEDICAL SCIENCES[Internet]. 2016;58(10):603-610. Available from: https://sid.ir/paper/52192/en

IEEE: Copy

SHOKOUFEH BONAKDARAN, and NASER SHOEIBI, “IS PLASMINOGEN ACTIVATOR INHIBITOR-1 ASSOCIATED WITH DIABETIC RETINOPATHY AND ITS SEVERITY IN TYPE 2 DIABETIC PATIENTS?,” MEDICAL JOURNAL OF MASHHAD UNIVERSITY OF MEDICAL SCIENCES, vol. 58, no. 10, pp. 603–610, 2016, [Online]. Available: https://sid.ir/paper/52192/en

Related Journal Papers